These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4444330)

  • 21. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
    Fuller TF; Brennan TV; Feng S; Kang SM; Stock PG; Freise CE
    J Urol; 2005 Dec; 174(6):2284-8. PubMed ID: 16280813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bilateral nephrectomy in patients in the final stage of renal failure with malignant hypertension].
    Simon V; Klemens J; Lachmanová J; Tomásek R
    Sb Lek; 1983 May; 85(5):141-6. PubMed ID: 6879104
    [No Abstract]   [Full Text] [Related]  

  • 23. A rapid instrumental method for the determination of dextran in urine.
    Clayton D; Philipson PE
    Biochem Med; 1972 Feb; 6(1):59-64. PubMed ID: 4623453
    [No Abstract]   [Full Text] [Related]  

  • 24. [Erythropoiesis in anephric patients].
    Blumberg A; Keller H
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1887-93. PubMed ID: 5141281
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combined use of neuroleptanalgesia and halothane in bilateral nephrectomy].
    Campion MC; Campion JP; Launois B
    Anesth Analg (Paris); 1976; 33(2):279-84. PubMed ID: 1008277
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indications for bilateral nephrectomy in patients with chronic renal failure].
    Sharon V; Kimche D
    Harefuah; 1973 Jan; 84(2):81-3. PubMed ID: 4704617
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrent unilateral or bilateral native nephrectomy in kidney transplant recipients.
    Dinckan A; Kocak H; Tekin A; Turkyilmaz S; Hadimioglu N; Ertug Z; Gunseren F; Ari E; Dinc B; Gurkan A; Yucel S
    Ann Transplant; 2013 Dec; 18():697-704. PubMed ID: 24356642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].
    Sadykov AS; Salikhov ShI; Mikhamedieva ShG; Kasymov ShK; Pak NP
    Biull Eksp Biol Med; 1984 Aug; 98(8):245-7. PubMed ID: 6466865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of molecular weights of colloidal dextran on human serum lipids.
    PUCAR Z; KELER-BACOKA M
    Science; 1961 Oct; 134(3487):1369-70. PubMed ID: 14489101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA; Chudnovskaia MV; Golovanov SA
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular permeability to serum proteins and high molecular weight dextrans in glomerulonephritis.
    Petrie JJ; MacLean PR; Robson JS
    Clin Sci; 1968 Feb; 34(1):83-95. PubMed ID: 5640686
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma aldosterone in chronic renal insufficiency and in anephric patients (author's transl)].
    Botey A; Bestard J; Mauri M; López Pedret J; Revert L
    Med Clin (Barc); 1979 Jul; 73(3):94-102. PubMed ID: 470511
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of bilateral nephrectomy on hemodynamics and body composition in patients with chronic renal failure.
    Zollinger RM; Skillman JJ; Gumpert JR; Hampers CL; Bailey GL; Merrill JP
    Surg Forum; 1969; 20():38-40. PubMed ID: 4910614
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemodynamic properties of low molecular dextran in experimental clinical conditions].
    Rudowski W; Kostrzewska E; Scharf R; Konopka L; Gregor A; Rechowicz K; Czartoryska B; Klawe Z; Ostrowski J
    Pol Tyg Lek; 1967 Oct; 22(45):1719-22. PubMed ID: 6063015
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal molecular weight for the blood substitute polyglucin.
    Rozenberg GY; From AA; Polushina TV; Chernysheva EA; Lavrova RI
    Fed Proc Transl Suppl; 1966; 25(5):805-8. PubMed ID: 5223564
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the electrocardiogramm in relation to electrolyte and pH shifts during hemodialysis].
    Steinbach K; Egert H
    Wien Z Inn Med; 1970; 51(8):366-75. PubMed ID: 5512985
    [No Abstract]   [Full Text] [Related]  

  • 38. Bilateral nephrectomy for renal failure and hypertension due to malignant nephrosclerosis.
    Stone WJ; Mauricio LD; Walker PJ; Johnson HK; Ginn HE
    Proc Clin Dial Transplant Forum; 1974; (4):66-9. PubMed ID: 4619666
    [No Abstract]   [Full Text] [Related]  

  • 39. Laparoscopic subcapsular nephrectomy.
    Moore RG; Chen RN; Hedican SP
    J Endourol; 1998 Jun; 12(3):263-4. PubMed ID: 9658299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma proteome profiling of von Hippel-Lindau disease after total and subtotal nephrectomy: a preliminary study.
    Opatrná S; Chiangjong W; Korabecná M; Sintiprungrat K; Sinchaikul S; Chen ST; Matejovic M; Thongboonkerd V
    Clin Biochem; 2010 Jan; 43(1-2):142-9. PubMed ID: 19715686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.